First Annual Review of Breast Cancer Highlights from International Medical Meetings

---

ONLINECMEConferences & Symposia

Thursday, July 16, 2020, 6:00 PM - 8:10 PM

This activity is designed to efficiently discuss the most recent clinical advances in breast cancer care. The meeting will address the questions that have emerged from the latest data presented at major international meetings such as ASCO and SABCS. Activity format will provide opportunity for interaction with Penn Medicine faculty and other attendees. Participants will gain up-to-date, practical information with immediate clinical application.

1. • Discuss clinical trial evidence that allows for the personalization of care in the management of early and advanced forms of breast cancer according to breast cancer phenotype
2. • Assess current and evolving roles for prognostic and predictive biomarkers to stratify risk and inform clinical decision making in the management of breast cancer
3. • Examine recent clinical trial results concerning the use of novel breast cancer treatment strategies

In support of improving patient care, Penn Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Penn Medicine designates this live activity for a maximum of 2.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AMA PRA Category 1 Credits™ (2.25 hours), Non-Physician Attendance / Participation (2.25 hours)

Thursday, July 16, 2020